Browsing by Subject "Nonalcoholic fatty liver disease"

Now showing items 1-2 of 2

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population

Zambrano-Huailla, Rommel; Guedes, Laura; Stefano, Jose Tadeu; de Souza, Arthur A. Arrais; Marciano, Sebastián; Yvamoto, Erika; Michalczuk, Matheus Truccolo; Vanni, Denise Siqueira; Rodriguez, Hernan; Carrilho, Flair Jose; Alvares-da-Silva, Mario Reis; Gadano, Adrian; Arrese, Marco; Miranda, Adelina Lozano; Oliveira, Claudia P. (Mexican Association of Hepatology, 2020-11-01)
Acceso abierto

Introduction and aims Several non-invasive scoring systems have been developed and validated worldwide to predict the risk of liver fibrosis in nonalcoholic fatty liver disease (NAFLD). However, information about the ...
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

Arab, Juan Pablo; Dirchwolf, Melisa; Álvares-da-Silva, Mário Reis; Barrera, Francisco; Benítez, Carlos; Castellanos-Fernandez, Marlene; Castro-Narro, Graciela; Chavez-Tapia, Norberto; Chiodi, Daniela; Cotrim, Helma; Cusi, Kenneth; de Oliveira, Claudia Pinto Marques Souza; Díaz, Javier; Fassio, Eduardo; Gerona, Solange; Girala, Marco; Hernandez, Nelia; Marciano, Sebastián; Masson, Walter; Méndez-Sánchez, Nahum; Leite, Nathalie; Lozano, Adelina; Padilla, Martín; Panduro, Arturo; Paraná, Raymundo; Parise, Edison; Perez, Marlene; Poniachik, Jaime; Restrepo, Juan Carlos; Ruf, Andrés; Silva, Marcelo; Tagle, Martín; Tapias, Monica; Torres, Kenia; Vilar-Gomez, Eduardo; Costa Gil, José Eduardo; Gadano, Adrian; Arrese, Marco (Mexican Association of Hepatology, 2020-11-01)
Acceso abierto

Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the general population. Furthermore, its prevalence ...

Browsing by Subject "Nonalcoholic fatty liver disease"

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population ﻿

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease ﻿

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease